1-2 of 2
Beata Jakubas, MD
Close
Sort by
Journal Articles

Role of Second Stem Cell Transplantation in Relapsed Lymphoproliferative Diseases: Remission Status Is the Most Important Factor Predicting the Outcome

Lidia Gil, MD PhD, Jan Styczynski, MD, PhD, Agnieszka Piekarska, MD PhD, Beata Jakubas, MD PhD, Katarzyna Drabko, MD PhD, Tomasz Wrobel, prof., Anna Czyz, MD PhD, Anna Lojko-Dankowska, MD PhD, Dominik Dytfeld, MD PhD, Adam Nowicki, MD, Patrycja Mensah-Glanowska, MD PhD, Wanda Knopinska-Posluszny, MD, PhD, Maria Bieniaszewska, MD PhD, Mariusz Wysocki, MD, PhD, Andrzej Hellmann, MD, PhD, Aleksander Skotnicki, Jerzy Kowalczyk, Kazimierz Kuliczkowski, MD PhD, prof., Mieczyslaw Komarnicki, MD PhD
Journal: Blood
Blood (2011) 118 (21): 3109.
https://doi.org/10.1182/blood.V118.21.3109.3109
Published: 2011
Journal Articles

The Reduction of Leukemic Blasts in Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia; the Results of Multicenter, Prospective Polish Adult Leukemia Group Trial.

Jerzy Holowiecki, Sebastian Grosicki, MD, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Marek Kielbinski, MD, Aleksander B. Skotnicki, Beata Jakubas, MD, Andrzej Hellmann, Tadeusz Robak, Marek J. Seweryn, MD, Beata Stella-Holowiecka, MD, Maria Sadus-Wojciechowska, MD
Journal: Blood
Blood (2007) 110 (11): 4375.
https://doi.org/10.1182/blood.V110.11.4375.4375
Published: 2007